GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like AstraZeneca PLC Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial February 16, 2017 Exactech Q1 Revenue Up 6% to $69.5 Million On 21% Extremities Growth April 25, 2017 Natus Medical Pays $48 Million for Integra LifeSciences' Neurosurgery Assets September 11, 2017
AstraZeneca PLC Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial February 16, 2017
